2022
DOI: 10.1016/j.ccell.2022.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
62
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 83 publications
(63 citation statements)
references
References 71 publications
1
62
0
Order By: Relevance
“…To further delineate expression of the chemokines of interest and the cognate receptors at the single-cell level, we reanalyzed a publicly available PDAC dataset ( 49 ), comprising single-cell RNAseq data from 12 RCC samples. Following cell type annotation, re-analysis revealed CXCL9 as well as CXCL10 expression mainly in myeloid cells, whereas CXCL11 was exclusively expressed in tumor cells.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…To further delineate expression of the chemokines of interest and the cognate receptors at the single-cell level, we reanalyzed a publicly available PDAC dataset ( 49 ), comprising single-cell RNAseq data from 12 RCC samples. Following cell type annotation, re-analysis revealed CXCL9 as well as CXCL10 expression mainly in myeloid cells, whereas CXCL11 was exclusively expressed in tumor cells.…”
Section: Resultsmentioning
confidence: 99%
“…(A) Overview of cellular localization of chemokines (CXCL9/10/11, CXCL13 and XCL1) and the cognate receptors (CXCR3, CXCR5 and XCR1). (B) Dotplot expression analysis of annotated myeloid subpopulations in the dataset ( 49 ) with targets CXCL9/10 and XCR1 demonstrating dendritic cells as the major source of XCR1 and M1 TAMs for CXCL9/10. As a representative member of the chemokine cluster, CXCL9 was further analyzed by flow cytometry.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…As such, this would complement the work of Li et al . [ 48 ] who studied ccRCC heterogeneity using a multi-region analysis of scRNA-seq and exome sequencing mutational landscapes.…”
Section: Discussionmentioning
confidence: 99%